The emerging role of obesity, diet and lipid metabolism in prostate cancer
- PMID: 27624840
- PMCID: PMC5619099
- DOI: 10.2217/fon-2016-0217
The emerging role of obesity, diet and lipid metabolism in prostate cancer
Abstract
Obesity is associated with an increased risk of a number of serious medical conditions, including cancer. As far as prostate cancer is concerned, obesity is associated with an increased risk of high-grade tumors, which is possibly related to lower androgen levels. Diet may also affect prostate cancer risk since countries with a higher dietary fat intake also present higher prostate cancer mortality rates. Interestingly, prostate cancer is associated with a number of metabolic alterations that may provide valuable diagnostic and therapeutic targets. This review explores the available clinical as well as biological evidence supporting the relationship between obesity, diet, alteration in metabolic pathways and prostate cancer.
Keywords: diet; obesity; urologic/prostate.
Conflict of interest statement
Figures
References
-
- Smith KB, Smith MS. Obesity statistics. Primary Care. 2016;43(1):121–135. - PubMed
-
- Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–79. - PubMed
-
- De Sousa AG, Cercato C, Mancini MC, Halpern A. Obesity and obstructive sleep apnea–hypopnea syndrome. Obes Rev. 2008;9(4):340–354. - PubMed
-
- Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–578. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical